Release Date: 28/05/15 13:53 Summary: Results of Extraordinary General Meeting Price Sensitive: No Download Document 336.93KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%